Meng, X., Bi, J., Li, Y., Yang, S., Zhang, Y., Li, M., . . . Leslie, K. K. (2018). AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations. Cancers (Basel).
Chicago Style CitationMeng, Xiangbing, et al. "AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells With P53 Mutations." Cancers (Basel) 2018.
Cita MLAMeng, Xiangbing, et al. "AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells With P53 Mutations." Cancers (Basel) 2018.
Atenció: Aquestes cites poden no estar 100% correctes.